ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Binh Dinh Pharmaceutical & Medical Equipment JSC ?
1
Poor long term growth as Net Sales has grown by an annual rate of 6.75% over the last 5 years
2
Flat results in Dec 25
- INTEREST(HY) At VND 2,341.93 MM has Grown at 29.77%
- ROCE(HY) Lowest at 17.2%
- OPERATING PROFIT(Q) Lowest at VND 71,108.06 MM
3
With ROE of 18.73%, it has a fair valuation with a 3.07 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -7.79%, its profits have risen by 15.5%
- At the current price, the company has a high dividend yield of 3
4
Below par performance in long term as well as near term
- Along with generating -7.79% returns in the last 1 year, the stock has also underperformed Vietnam VN Ho Chi Minh Index in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Binh Dinh Pharmaceutical & Medical Equipment JSC for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Binh Dinh Pharmaceutical & Medical Equipment JSC
-10.58%
1.16
21.38%
Vietnam VN Ho Chi Minh Index
16.45%
1.90
22.90%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.70%
EBIT Growth (5y)
13.60%
EBIT to Interest (avg)
77.95
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
1.03
Tax Ratio
15.70%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
23.58%
ROE (avg)
17.11%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
2.66
EV to EBIT
14.23
EV to EBITDA
12.35
EV to Capital Employed
2.99
EV to Sales
2.42
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
21.00%
ROE (Latest)
15.96%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
OPERATING CASH FLOW(Y)
Highest at VND 510,635.32 MM
CASH AND EQV(HY)
Highest at VND 1,182,660.74 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 2.29 times
-6What is not working for the Company
INTEREST(9M)
At VND 3,182.13 MM has Grown at 26.06%
ROCE(HY)
Lowest at 16.34%
RAW MATERIAL COST(Y)
Grown by 11.65% (YoY
Here's what is working for Binh Dinh Pharmaceutical & Medical Equipment JSC
Operating Cash Flow
Highest at VND 510,635.32 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (VND MM)
Cash and Eqv
Highest at VND 1,182,660.74 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 2.29 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Binh Dinh Pharmaceutical & Medical Equipment JSC
Interest
At VND 3,182.13 MM has Grown at 26.06%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (VND MM)
Raw Material Cost
Grown by 11.65% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
